News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Meyenburg Jason Patrick
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/05/2022 |
4
| Meyenburg Jason Patrick (CEO) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Granted 123,600 restricted stock units
@ $0 |
|
| 05/18/2021 |
4
| Meyenburg Jason Patrick (President & CEO) has filed a Form 4 on Gemini Therapeutics, Inc. /DE|
Txns:
| Bought 13,000 shares
@ $9.4561, valued at
$122.9k
|
|
| 04/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
3
| Meyenburg Jason Patrick (President & CEO) has filed a Form 3 on Gemini Therapeutics, Inc. /DE |
| 02/13/2018 |
4
| Meyenburg Jason Patrick (Chief Commercial Officer) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 30,228 shares
@ $18, valued at
$544.1k
Disposed/sold 150,000 options to buy
@ $10.65, valued at
$1.6M
|
|
| 09/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|